📧 Communication

access_code

← Back to List

Communication Details

From

Not specified Linked to Not specified

Not specified Not specified

Subject

Access Code

Message Content

81662098

📄 Source Document

HOUSE_OVERSIGHT_026366.jpg

ESTATE Collection

View Document

Document Summary

This document is a corporate communication and product information sheet for the prescription drug Praluent (alirocumab), manufactured by Sanofi. It details the ODYSSEY clinical trial program, provides important safety information for patients, and includes a legal disclaimer. The document is marked with the identifier 'HOUSE_OVERSIGHT_026366' but contains no information whatsoever related to Jeffrey Epstein, his associates, finances, or travel.

Discussion 0

No comments yet

Be the first to share your thoughts on this epstein communication